The Audacious Medical Grant (AMG) is a funding tool financed by private donations and bequests received by the FNRS.
It supports medical or biomedical research projects that are original, audacious, and creative but do not find support in traditional funding channels due to a lack of preliminary data, absence of prior work, or an unconventional methodology.
The AMG-ONCO is not a funding instrument dependent on Télévie, but the FNRS uses the expertise of its Scientific Committee to evaluate the submitted projects. Therefore, there is no overlap between the AMG-ONCO 2025 call and the Télévie 2025 call.
This call covers all areas of oncology and all approaches (biomedical research, clinical research, epidemiological research, public health…). The submitted project must aim to:
-
Improve the understanding of the mechanisms leading to cancer development, and/or
-
Develop new therapeutic avenues, and/or
-
Improve cancer prevention or detection.
The AMG-ONCO 2025 call is open until February 27, 2025.
